Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 314 (5804): 1370-

Copyright © 2006 by the American Association for the Advancement of Science

MEDICINE:
Squelching Progesterone's Signal May Prevent Breast Cancer

Jean Marx

Results described on page 1467 of this issue of Science suggest that one day it may be possible to use progesterone-blocking drugs rather than surgery to prevent BRCA1-mediated breast cancers. (Read more.)


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Translational Efficacy of a Nonsteroidal Progesterone Receptor Antagonist, 4-[3-Cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on Endometrial Growth in Macaque and Human.
D. C. Howe, N. M. Mount, K. Bess, A. Brown, P. Bungay, K. R. Gibson, T. Hawcock, J. Richard, G. Jones, R. Walley, et al. (2011)
J. Pharmacol. Exp. Ther. 339, 642-653
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882